Enterprise Tech Ecosystem Series - Medtronic plc
Summary
Medtronic Plc (Medtronic), founded in the year 1949, is a medical technology, solutions and services company which designs, develops, manufactures and markets a wide range of medical devices and solutions for the treatment of heart failure; heart valve disorders; diseases of the coronary artery; aortic; peripheral vascular; venous renal and neurological diseases; spine and musculoskeletal disorders; and diseases of the ear, nose and throat
Scope
The report provides information and insights into Medtronic plc, including:
Reasons to Buy
Summary
Medtronic Plc (Medtronic), founded in the year 1949, is a medical technology, solutions and services company which designs, develops, manufactures and markets a wide range of medical devices and solutions for the treatment of heart failure; heart valve disorders; diseases of the coronary artery; aortic; peripheral vascular; venous renal and neurological diseases; spine and musculoskeletal disorders; and diseases of the ear, nose and throat
Scope
The report provides information and insights into Medtronic plc, including:
- Insights of its digital transformation strategies
- Details of various partnerships, innovation centers, accelerator programs, network map, in-house launches, and other industry innovation programs
- Detailed overview of Medtronic plc's technology centers and innovation programs and financial highlights.
Reasons to Buy
- Gain insights into Medtronic Plc technology innovations.
- Gain insights into its Digital Transformation Strategy.
- Gain insights into various product launches, partnership strategies of Medtronic Plc.
- Gain insights into various disruptive technologies and tech initiatives of the Company.
Table of Contents
- Overview
- Digital Transformation Strategy
- Accelerator Programs & Innovation Centers
- Technology Focus
- Technology Initiatives
- Investments & Acquisitions
- Partner, Investor, & Acquisition Network Map
- ICT Budget
- Key Executives
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Viz
- American Well
- IBM
- Novo Nordisk
- Samsung
- Eris Lifesciences